The Motley Fool

3 penny stocks I’d buy to hold for 10 years

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A pile of British one penny coins on a white background.
Image source: Getty Images

Buying penny stocks can be a wild ride for UK share investors. Their low cost means bouts of extreme share price volatility can be commonplace. But so what? As a long-term investor, I for one am not discouraged from buying ultra-cheap stocks. This is because quality stocks tend to rise in value over a period of years, regardless of what they cost initially.

Here are what I think could be some of the best penny stocks to buy for the next 10 years.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

One cheap UK share on my radar

I fully expect Assura to provide decent stress-free returns for the next decade at least. This penny stock invests in and rents out primary healthcare facilities in the UK.

Not only can this UK share expect demand for its properties to keep rising as a rapidly-ageing population drives healthcare services usage. But the company remains committed to its successful acquisition strategy in order to drive future earnings.

Besides, investors in Assura don’t need to be concerned about the impact of economic crashes on its profits, given the ultra-defensive sector in which it operates. I’d buy this stock despite the fact that an acquisition-led growth strategy can create a multitude of problems like disappointing revenues and ballooning costs.

A penny stock in top shape

Glanbia is another penny stock I’d happily buy today to own for the next 10 years. This is because the sports nutrition market is expected to continue growing rapidly, a sector in which it manufactures ingredients for and services directly through brands such as Optimum Nutrition.

Statista, for example, thinks the global sports nutrition and supplements market will be worth $35.4bn by 2025. That compares with the $13.9bn it was worth in 2018.

Indeed, business is already booming at Glanbia. Like-for-like sales at its Performance Nutrition and  Nutritionals units leapt 14.1% and 7.9% respectively in the three months to 3 April. I’d buy this UK share despite the rising popularity of veganism and the threat this poses to its dairy operations.

Get in the fast lane

A bright outlook for the sports car markets means Surface Transforms also has a very bright future indeed. Okay, demand for luxury and fast cars took a smack in 2020 as the Covid-19 crisis took hold.

And there’s the possibility of the public health emergency blowing up again, posing a risk to carmakers and parts manufacturers in the short-to-medium term.

However, over a longer time horizon, the outlook remains pretty exciting. That’s because the number of millionaires (and billionaires) is tipped to grow. Analysts at Knight Frank think the number of ultra-high net worth individuals ($30m+) will soar 27% in the five years to 2025.

It’s a trend which performance brake manufacturer and penny stock Surface Transforms stands to benefit greatly from.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Glanbia. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.